Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pré-Eclampsie et Retard de Croissance: Une étude Longitudinale Évaluative (PERLE)

NCT02379832 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT02379832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02379832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pré-Eclampsie et Retard de Croissance: Une étude Longitudinale Évaluative (PERLE)
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
December 31, 2017
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction, preeclampsia, preterm birth, severe preeclampsia